{
  "tool": "tavily",
  "query": "abridge company last_round_name",
  "results": [
    {
      "title": "Abridge Inc - 2025 Company Profile & Team",
      "content": "## Abridge Inc - About the company Abridge Inc is a series E company based in Pittsburgh (United States), founded in 2018byZachary Zack Lipton, Florian Metze, Shivdev Rao and Sandeep Konam. Abridge Inc has raised $773M in funding from investors like Lightspeed Venture Partners, Redpoint Ventures and Andreessen Horowitz, with a current valuation of $5.3B. | 1st | Abridge Inc 2018, Pittsburgh (United States), Series E | Provider of AI-based health record platform | $773M | IVP, CapitalG\u00a0&\u00a030\u00a0others | 70/100 | Abridge Inc is a funded company, having raised a total of $773M across 6 funding rounds to date. Abridge Inc's latest funding was a $316M Series E round on Jun 12, 2025, led byAndreessen Horowitz.",
      "url": "https://tracxn.com/d/companies/abridge-inc/__Pa9JE2faVUirY8e07Tb0M33vLUKKRf0BPr2xbtBzrq8"
    },
    {
      "title": "Abridge - Crunchbase Company Profile & Funding",
      "content": "Abridge is an AI-driven platform that transforms patient-clinician conversations into structured clinical notes for healthcare industries.",
      "url": "https://www.crunchbase.com/organization/abridge-d1a4"
    },
    {
      "title": "Abridge Emerges as a Healthcare AI Leader, Raising $150M",
      "content": "PITTSBURGH, PA (February 23, 2024) \u2013 Abridge, the leader in generative AI for clinical documentation, announced an additional $150 million investment, leveraging momentum from their product\u2019s rapid uptake among health systems throughout the nation. This raise comes just 4 months after their [$30M Series B](https://www.abridge.com/press/abridge-raises-30m-to-accelerate-adoption-of-its-proven-generative-ai-solution-across-u-s-healthcare-systems), and is one of the largest funding rounds made to date in generative AI for healthcare. \u201cAbridge has set new standards for quality and responsible deployment of generative AI in health systems across the U.S., cementing it as the industry\u2019s most trusted AI platform,\u201d said Sebastian Duesterhoeft, Partner at Lightspeed Venture Partners. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems.",
      "url": "https://www.abridge.com/press-release/series-c-150"
    },
    {
      "title": "Healthcare startup Abridge raises $250 million to enhance ...",
      "content": "# Healthcare startup Abridge raises $250 million to enhance AI capabilities Feb 17 (Reuters) - Abridge, a startup that uses artificial intelligence to build medical documents, said on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. AI startups captured a record 46.4% of the total $209 billion raised, opens new tab by U.S. startups in 2024, compared with less than 10% a decade earlier. The company was valued at $850 million after a funding round last year, in which it had raised $150 million. The healthcare startup said that the latest funding will help it develop AI capabilities and grow commercially.",
      "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-startup-abridge-raises-250-million-enhance-ai-capabilities-2025-02-17/"
    },
    {
      "title": "Abridge scores $300M series E, boosting valuation to $5.3B",
      "content": "Expanding its gen AI tools to the inpatient setting opens up an entirely new surface area for innovation, Shiv Rao, M.D., Abridge CEO and a practicing cardiologist, told Fierce Healthcare last week The company's new capabilities and features represent how Abridge \"is going millions of miles deep\" on developing gen AI tools for different care settings and different clinical workflows, Rao told Fierce Healthcare. Abridge Andreessen Horowitz Khosla Ventures funding round venture capital (VC) electronic health records (EHRs) ambient AI generative AI Artificial Intelligence Revenue Cycle Management Finance Health Tech Hospitals Practices Providers AI and Machine Learning",
      "url": "https://www.fiercehealthcare.com/ai-and-machine-learning/ambient-ai-startup-abridge-scores-300m-series-e-backed-a16z-and-khosla"
    }
  ],
  "raw_content": "\nAbridge Inc - 2025 Company Profile & Team\n## Abridge Inc - About the company Abridge Inc is a series E company based in Pittsburgh (United States), founded in 2018byZachary Zack Lipton, Florian Metze, Shivdev Rao and Sandeep Konam. Abridge Inc has raised $773M in funding from investors like Lightspeed Venture Partners, Redpoint Ventures and Andreessen Horowitz, with a current valuation of $5.3B. | 1st | Abridge Inc 2018, Pittsburgh (United States), Series E | Provider of AI-based health record platform | $773M | IVP, CapitalG\u00a0&\u00a030\u00a0others | 70/100 | Abridge Inc is a funded company, having raised a total of $773M across 6 funding rounds to date. Abridge Inc's latest funding was a $316M Series E round on Jun 12, 2025, led byAndreessen Horowitz.\n\nAbridge - Crunchbase Company Profile & Funding\nAbridge is an AI-driven platform that transforms patient-clinician conversations into structured clinical notes for healthcare industries.\n\nAbridge Emerges as a Healthcare AI Leader, Raising $150M\nPITTSBURGH, PA (February 23, 2024) \u2013 Abridge, the leader in generative AI for clinical documentation, announced an additional $150 million investment, leveraging momentum from their product\u2019s rapid uptake among health systems throughout the nation. This raise comes just 4 months after their [$30M Series B](https://www.abridge.com/press/abridge-raises-30m-to-accelerate-adoption-of-its-proven-generative-ai-solution-across-u-s-healthcare-systems), and is one of the largest funding rounds made to date in generative AI for healthcare. \u201cAbridge has set new standards for quality and responsible deployment of generative AI in health systems across the U.S., cementing it as the industry\u2019s most trusted AI platform,\u201d said Sebastian Duesterhoeft, Partner at Lightspeed Venture Partners. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems.\n\nHealthcare startup Abridge raises $250 million to enhance ...\n# Healthcare startup Abridge raises $250 million to enhance AI capabilities Feb 17 (Reuters) - Abridge, a startup that uses artificial intelligence to build medical documents, said on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. AI startups captured a record 46.4% of the total $209 billion raised, opens new tab by U.S. startups in 2024, compared with less than 10% a decade earlier. The company was valued at $850 million after a funding round last year, in which it had raised $150 million. The healthcare startup said that the latest funding will help it develop AI capabilities and grow commercially.\n\nAbridge scores $300M series E, boosting valuation to $5.3B\nExpanding its gen AI tools to the inpatient setting opens up an entirely new surface area for innovation, Shiv Rao, M.D., Abridge CEO and a practicing cardiologist, told Fierce Healthcare last week The company's new capabilities and features represent how Abridge \"is going millions of miles deep\" on developing gen AI tools for different care settings and different clinical workflows, Rao told Fierce Healthcare. Abridge Andreessen Horowitz Khosla Ventures funding round venture capital (VC) electronic health records (EHRs) ambient AI generative AI Artificial Intelligence Revenue Cycle Management Finance Health Tech Hospitals Practices Providers AI and Machine Learning\n",
  "count": 5,
  "success": true
}